We tested whether the administration of a specific vitamin preparation containing L-methylfolate (Ocufolin forte) as an addition to anti-VEGF therapy reduces these two risk factors and favorably influences the disease course. A total of 27 eyes/27 patients with intra- and subretinal fluid, Hcy ...